23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

After Hours

 --Real time quotes

Feb 8, 2023, 4:31 p.m.

ME
/zigman2/quotes/222659849/composite

$

2.75

Change

+0.23 +9.13%

Volume

Volume 78,770

Real time quotes

/zigman2/quotes/222659849/composite

Today's close

$ 2.53

$ 2.52

Change

-0.01 -0.40%

Day low

Day high

$2.47

$2.58

Open

52 week low

52 week high

$2.02

$6.31

Open

Kathy L. Hibbs

Currently, Kathy L. Hibbs is Secretary & Chief Administrative Officer at 23andMe Holding Co. and Chief Administrative Officer at 23andMe, Inc. (a subsidiary of 23andMe Holding Co.). Ms. Hibbs is also on the board of SOPHiA GENETICS SA and Cadex Genomics Corp.

Kathy L. Hibbs previously occupied the position of Secretary, Senior Vice President & General Counsel at Monogram Biosciences, Inc., Secretary, Senior Vice President & General Counsel at Genomic Health, Inc., Director-Legal Affairs at Varian Medical Systems, Inc., Counsel at Granite Bank, FSB (San Francisco, California) and Vice President & General Counsel of Multitude, Inc.

Ms. Hibbs received an undergraduate degree from the University of California, Riverside and a graduate degree from the University of California, Hastings.

Transactions

Date Shares Transaction Value
12/05/2022 26,259   Disposition at $3.25 per share. 85,342
11/20/2022 4,628   Derivative/Non-derivative trans. at $2.99 per share. 13,838
08/20/2022 4,628   Derivative/Non-derivative trans. at $3.33 per share. 15,412
06/01/2022 4,627   Derivative/Non-derivative trans. at $2.82 per share. 13,049
02/09/2022 214,091   Award at $0 per share. 0
01/06/2022 58,800   Derivative/Non-derivative trans. at $0.42 per share. 24,696

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Dr. D. Wade Walke
Vice President-Investor Relations
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.